Lundbeck
HLUN-B.CO
#2091
Rank
โ‚น815.10 B
Marketcap
โ‚น821.55
Share price
-2.27%
Change (1 day)
35.42%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): โ‚น69.37

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น70.47. In 2025 the company made an earnings per share (EPS) of โ‚น46.93 an increase over its 2024 EPS that were of โ‚น40.99.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น69.3747.8%
2025โ‚น46.9314.5%
2024โ‚น40.9929.29%
2023โ‚น31.7023.09%
2022โ‚น25.7637.26%
2021โ‚น18.76-84.61%
2020โ‚น121.93-24.61%
2019โ‚น161.73-42.06%
2018โ‚น279.1440.7%
2017โ‚น198.40146.26%
2016โ‚น80.56-120.48%
2015-โ‚น393.293231.32%
2014-โ‚น11.81-115.78%
2013โ‚น74.81-23.36%
2012โ‚น97.61-48.01%
2011โ‚น187.76-9.68%
2010โ‚น207.8913.72%
2009โ‚น182.8024.32%
2008โ‚น147.05-6.05%
2007โ‚น156.5181.77%
2006โ‚น86.10-16.76%
2005โ‚น103.44-17.58%
2004โ‚น125.51